Luken Investment Analytics’s AbbVie ABBV Stock Holding History

Luken Investment Analytics’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.5K	Sell	131 -12	-8%	-$2.66K	0.01%	114
2025 Q4	$32.7K	Buy	143 +59	+70%	+$13.4K	0.01%	108
2025 Q3	$19.4K	Hold	84	–	–	0.01%	117
2025 Q2	$15.6K	Hold	84	–	–	0.01%	119
2025 Q1	$17.6K	Hold	84	–	–	0.01%	117
2024 Q4	$14.9K	Hold	84	–	–	0.01%	113
2024 Q3	$16.6K	Hold	84	–	–	0.01%	105
2024 Q2	$14.4K	Hold	84	–	–	0.01%	120
2024 Q1	$15.3K	Hold	84	–	–	0.01%	106
2023 Q4	$13K	Hold	84	–	–	0.01%	111
2023 Q3	$12.5K	Hold	84	–	–	0.01%	113
2023 Q2	$11.3K	Hold	84	–	–	0.01%	114
2023 Q1	$13.4K	Hold	84	–	–	0.01%	107
2022 Q4	$13.6K	Buy	+84	New	+$12.9K	0.01%	105
2020 Q4	$9K	Buy	+84	New	+$8.07K	0.01%	86

Other funds holding ABBV

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return